Give a Christmas gift to our researchers Donate a gift to our researchers and help fund life-saving treatments this Christmas.
Home About us Media Breast Cancer Now media statements 217 results We support recommendations for faster and wider access to innovative cancer treatments 09 Nov 2020 1 min read We respond to news that the pandemic ‘threatens research as early career scientists look to leave’ 10 Nov 2020 1 min read We respond to a BMJ Study that provides new estimates of breast cancer risks associated with HRT 10 Nov 2020 1 min read We respond to NHS England breast cancer waiting times: September 2020 and Q2 20/21 12 Nov 2020 4 min read Response to the Spending Review 2020 25 Nov 2020 2 min read We respond to the Scotland Cancer Recovery Plan 10 Dec 2020 1 min read We respond to RxPONDER trial results that suggest postmenopausal women with early-stage breast cancer/low recurrence score could skip adjuvant chemo 10 Dec 2020 1 min read We respond to NHS England breast cancer waiting times: October 2020 10 Dec 2020 3 min read We respond to NHS England breast cancer waiting times for November 2020 14 Jan 2021 3 min read We Respond to Breast Cancer Screening Performance Data for England 2019/20 28 Jan 2021 3 min read We respond to breast cancer becoming the most common cancer globally 05 Feb 2021 1 min read We respond to draft NICE decision not to recommend abemaciclib with fulvestrant for routine use on the NHS 12 Feb 2021 3 min read Previous 1 ... 18 19 Next
We support recommendations for faster and wider access to innovative cancer treatments 09 Nov 2020 1 min read
We respond to news that the pandemic ‘threatens research as early career scientists look to leave’ 10 Nov 2020 1 min read
We respond to a BMJ Study that provides new estimates of breast cancer risks associated with HRT 10 Nov 2020 1 min read
We respond to NHS England breast cancer waiting times: September 2020 and Q2 20/21 12 Nov 2020 4 min read
We respond to RxPONDER trial results that suggest postmenopausal women with early-stage breast cancer/low recurrence score could skip adjuvant chemo 10 Dec 2020 1 min read
We respond to draft NICE decision not to recommend abemaciclib with fulvestrant for routine use on the NHS 12 Feb 2021 3 min read
